179 related articles for article (PubMed ID: 17681045)
21. [The roles of PPARs in digestive diseases].
Nakajima A; Yoneda M; Takahashi H; Fujisawa N; Wada K
Nihon Rinsho; 2005 Apr; 63(4):665-71. PubMed ID: 15828235
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
[TBL] [Abstract][Full Text] [Related]
23. [Autoimmune disease].
Yoshikawa T; Kawahito Y
Nihon Rinsho; 2005 Apr; 63(4):687-90. PubMed ID: 15828238
[TBL] [Abstract][Full Text] [Related]
24. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
Kravchenko NA; Iarmysh NV
Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
[TBL] [Abstract][Full Text] [Related]
25. The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.
Lendvai Á; Deutsch MJ; Plösch T; Ensenauer R
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E797-810. PubMed ID: 26860983
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
[TBL] [Abstract][Full Text] [Related]
28. Ligand specificity of nuclear hormone receptors: sifting through promiscuity.
Noy N
Biochemistry; 2007 Nov; 46(47):13461-7. PubMed ID: 17983246
[TBL] [Abstract][Full Text] [Related]
29. [Roles of PPARs in carcinogenesis].
Imamura K; Lu J; Kaminishi M
Nihon Rinsho; 2005 Apr; 63(4):584-8. PubMed ID: 15828224
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of synthetic sphingolipid analogs as ligands for peroxisome proliferator-activated receptors.
Tsuji K; Satoh S; Mitsutake S; Murakami I; Park JJ; Li Q; Chang YT; Chung SK; Igarashi Y
Bioorg Med Chem Lett; 2009 Mar; 19(6):1643-6. PubMed ID: 19237283
[TBL] [Abstract][Full Text] [Related]
31. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome.
Huang TH; Kota BP; Razmovski V; Roufogalis BD
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):3-14. PubMed ID: 15667590
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
Komar CM
Reprod Biol Endocrinol; 2005 Aug; 3():41. PubMed ID: 16131403
[TBL] [Abstract][Full Text] [Related]
33. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor.
Rau O; Wurglics M; Dingermann T; Abdel-Tawab M; Schubert-Zsilavecz M
Pharmazie; 2006 Nov; 61(11):952-6. PubMed ID: 17152989
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors and placental function in women with polycystic ovary syndrome.
Silva A; Motta A
Reproduction; 2024 May; 167(5):. PubMed ID: 38451874
[TBL] [Abstract][Full Text] [Related]
35. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
Zieleniak A; Wójcik M; Woźniak LA
Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
[TBL] [Abstract][Full Text] [Related]
36. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
Genini D; Catapano CV
J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
[TBL] [Abstract][Full Text] [Related]
37. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB
Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
[TBL] [Abstract][Full Text] [Related]
38. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
Guri AJ; Hontecillas R; Bassaganya-Riera J
J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
[TBL] [Abstract][Full Text] [Related]
39. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.
Ziouzenkova O; Plutzky J
FEBS Lett; 2008 Jan; 582(1):32-8. PubMed ID: 18068127
[TBL] [Abstract][Full Text] [Related]
40. PPAR agonists and the metabolic syndrome.
Staels B
Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
